Two doses of CoronaVac, a Covid-19 vaccine manufactured by Chinese firm Sinovac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a results of phase 1/2 clinical trial published in The Lancet Infectious Diseases journal....
Pfizer and Moderna vaccines, the first two jabs authorised for emergency use against Covid-19 by the US Food and Drug Administration (FDA), produce immune responses that are both strong and potentially long-lasting, finds a study....
Many people are complaining of fungal and bacterial ear infections, and the number has seen an uptrend during the rainy season. To avoid ear infections, keep your ears clean and manage red flags like reduced hearing, pain, and watery discharge, say experts....
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant....
Covid-19 positive patients with traumatic injuries, such as from car crashes, falls or other accidents, or those who were victims of violent injuries such as gunshots and stabbings, are six times more at risk of death and complication than such patients without the deadly infectious disease, research shows....
Dr. Reddy's Laboratories on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG) for treatment of Covid-19....
Israeli Prime Minister Naftali Bennett has urged teenagers in the country to get vaccinated against Covid-19 amid rising numbers of new cases due to a local outbreak of the Delta variant....
With 35,204 new cases of the Delta Covid-19 variant getting reported last week, the UK has seen a 46 per cent increase in the variant of concern, the Public Health England (PHE) said on Friday. ...
Indonesia is currently examining the use of the Sinovac and Pfizer Covid-19 vaccines for people under 18 years of age after detecting many cases of the highly contagious Delta variant of the coronavirus among children and youths....
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) -- used for arthritis -- for the treatment of hospitalised patients with Covid-19....
